![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
FC Chen, HI Yamamura and WR Roeske
We have demonstrated previously a postnatal peak for the beta adrenergic receptor in the heart and detected the appearance of a beta adrenergic receptor before an (-)-isoproterenol inducible increase in heart rate. The present study examined 1) agonist displaceable [3H] dihydroalprenolol (DHA) binding in the neonatal and adult mouse heart and 2) adenylate cyclase in fetal, neonatal and adult mouse heart. 3[H]DHA binding displaceable by (-)-isoproterenol gave a similar Ki from 1 day neonate through adult. Similar to the result found for antagonist displacement binding, there was a dramatic increase in the agonist displaceable [3H] DHA binding postnatally. The maximum was achieved in 2 weeks and then gradually declined to adult level. Cyclase activity (basal, (-)-isoproterenol- and NaF- stimulated) paralleled beta adrenergic receptor increases before birth. However, no early postnatal peak was present. In the 13 day fetal mouse heart, there is no (-)-isoproterenol increase in heart rate, but beta adrenergic receptor (13 +/- 4% of adult) and (-)-isoproterenol-stimulated adenylate cyclase activity (15 +/- 5% of adult) are present. It is concluded that 1) no significant difference exists between the agonist and antagonist displaceable [3H] DHA binding during development, 2) adenylate cyclase activity increases significantly during the last third of pregnancy in parallel with the beta adrenergic receptor, 3) both the beta adrenergic receptor and adenylate cyclase activity can be detected before the heart rate responses and 4) total adenylate cyclase activity does not increase in parallel with the early postnatal beta adrenergic receptor peak.
This article has been cited by other articles:
|
|
 |
|
  M.-H. Huang, J. J. Bahl, Y. Wu, F. Hu, D. F. Larson, W. R. Roeske, and G. A. Ewy Neuroendocrine properties of intrinsic cardiac adrenergic cells in fetal rat heart Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H497 - H503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-Q. Zhou, F. S. Foster, R. Parkes, and S. L. Adamson Developmental changes in left and right ventricular diastolic filling patterns in mice Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1563 - H1575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Portbury, R. Chandra, M. Groelle, M. K. McMillian, A. Elias, J. R. Herlong, M. Rios, S. Roffler-Tarlov, and D. M. Chikaraishi Catecholamines act via a beta -adrenergic receptor to maintain fetal heart rate and survival Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2069 - H2077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Liu, K. Yasui, A. Arai, K. Kamiya, J. Cheng, I. Kodama, and J. Toyama beta -Adrenergic modulation of L-type Ca2+-channel currents in early-stage embryonic mouse heart Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H608 - H613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.H. An, M.P. Davies, P.A. Doevendans, S.W. Kubalak, R. Bangalore, K.R. Chien, and R.S. Kass Developmental Changes in ß-Adrenergic Modulation of L-Type Ca2+ Channels in Embryonic Mouse Heart Circ. Res., March 1, 1996; 78(3): 371 - 378. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
